STOCK TITAN

Agilent Technologies Inc. - A STOCK NEWS

Welcome to our dedicated page for Agilent Technologies news (Ticker: A), a resource for investors and traders seeking the latest updates and insights on Agilent Technologies stock.

Agilent Technologies Inc., originally spun out of Hewlett-Packard in 1999, has evolved into a leading firm in the life sciences and diagnostics sector. The company specializes in creating advanced measurement technologies that serve a vast range of customers across various industries.

The company's core business revolves around three main segments: life science and applied tools, cross lab (which includes consumables and services related to life sciences and applied tools), and diagnostics and genomics. These segments collectively cater to a broad spectrum of markets, including biopharmaceuticals, chemicals, advanced materials, clinical labs, environmental testing, forensics, food safety, academic research, and government-related organizations.

Agilent's geographical reach is extensive, with significant operations in the U.S. and China. The company is committed to addressing global trends impacting human health and the environment and continuously anticipates future scientific needs.

Agilent provides comprehensive laboratory solutions that enhance the efficiency of laboratories, from sample preparation to data interpretation and management. Their instruments, software, services, and consumables are designed to meet the most complex laboratory demands, empowering scientists and researchers worldwide to make impactful discoveries and improvements in various fields.

Recent achievements include advancements in biopharmaceutical technology, collaborations with leading research institutions, and the launch of state-of-the-art diagnostic tools. The company also emphasizes sustainable practices and innovations aimed at improving human health and environmental outcomes.

Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) has been included in the Dow Jones Sustainability World Index and the North America Index for its strong environmental, social, and governance (ESG) performance. The company has been named in the Dow Jones Sustainability Indices for a ninth consecutive year, with only 3,500 of the largest companies globally eligible for inclusion. Agilent's sustainability performance was scored 'very high' on the S&P Global's annual Corporate Sustainability Assessment (CSA), far above the industry average in all three categories. The company is named in both the Dow Jones Sustainability World Index and the Dow Jones Sustainability North America Index, marking the ninth year of its inclusion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.34%
Tags
none
-
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) has moved its Cell Analysis Division into its Diagnostics and Genomics Group (DGG) to strengthen growth opportunities. This strategic move aims to align with customer needs and expand workflow coverage for accelerated growth. The company's cell analysis work, driven by acquisitions of BioTek Instruments, ACEA Biosciences, and Seahorse Bioscience, has been a significant growth driver. Agilent will report under the new structure starting from the first quarter fiscal 2024 results and will recast historical segment information accordingly.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.15%
Tags
none
-
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) CEO and CFO to present at 42nd Annual J.P. Morgan Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.55%
Tags
conferences
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) has been recognized by the World Economic Forum as a Global Lighthouse for its manufacturing facility in Waldbronn, Germany. The facility is lauded for its innovative use of Fourth Industrial Revolution technologies, making it a model of smart manufacturing. Agilent is one of only 153 facilities worldwide to receive this distinction, and the only analytical and clinical laboratory technology company to be recognized.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.16%
Tags
none
-
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) announced that the Agilent Resolve Handheld Raman Spectrometer has been recognized for excellence as a tool for emergency responders by the UK’s National CBRN Centre and the US’ Department of Homeland Security.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.18%
Tags
none
-
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) introduces water immersion and new confocal spinning disk technology to the BioTek Cytation C10 confocal imaging reader. These features enhance image quality for live-cell and 3D applications, reducing deleterious effects on live-cell samples and improving clarity for thicker samples such as tissues and 3-D spheroids.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.07%
Tags
none
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) reported revenue of $1.69 billion for Q4 2023, down 8.7% reported and 9.7% core(1) from Q4 2022. GAAP net income was $475 million; EPS was $1.62, up 32% from Q4 2022. Full fiscal year 2023 revenue was $6.83 billion, flat on a reported basis and up 1.5% core(1) year-over-year. For fiscal year 2024, revenue is expected between $6.71 billion to $6.81 billion, and non-GAAP EPS in the range of $5.44 to $5.55 per share.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.72%
Tags
-
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) to present at Evercore ISI HealthCONx conference on Nov. 29. President and CEO, Mike McMullen, and CFO, Bob McMahon, will lead the virtual session. The webcast will be available on Agilent's Investor Relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.91%
Tags
conferences
-
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) Increases Quarterly Dividend by 5% to 23.6 Cents Per Share
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
dividends
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) has received FDA approval for PD-L1 IHC 22C3 pharmDx as a diagnostic tool to identify patients with Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma eligible for treatment with KEYTRUDA® (pembrolizumab). This marks the sixth cancer type for which PD-L1 IHC 22C3 pharmDx has gained FDA approval, highlighting Agilent's leadership in developing companion diagnostics for anti-PD-1 therapies. PD-L1 IHC 22C3 pharmDx also aids in identifying patients with non-small cell lung cancer, esophageal squamous cell carcinoma, cervical cancer, head and neck squamous cell carcinoma, and triple-negative breast cancer suitable for treatment with KEYTRUDA.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.86%
Tags

FAQ

What is the current stock price of Agilent Technologies (A)?

The current stock price of Agilent Technologies (A) is $152.57 as of January 21, 2025.

What is the market cap of Agilent Technologies (A)?

The market cap of Agilent Technologies (A) is approximately 43.0B.

What does Agilent Technologies Inc. specialize in?

Agilent specializes in life sciences, diagnostics, and measurement technologies, providing advanced solutions and services for laboratories.

When was Agilent Technologies Inc. founded?

Agilent Technologies was spun out of Hewlett-Packard in 1999.

What are the main business segments of Agilent Technologies Inc.?

Agilent operates in three main segments: life science and applied tools, cross lab, and diagnostics and genomics.

Which industries does Agilent Technologies Inc. serve?

Agilent serves industries such as biopharmaceuticals, chemicals, advanced materials, clinical labs, environmental testing, forensics, food safety, academic research, and government organizations.

Where are Agilent Technologies Inc.'s main operations located?

Agilent's main operations are located in the U.S. and China.

What recent achievements has Agilent Technologies Inc. made?

Recent achievements include advancements in biopharmaceutical technology, collaborations with research institutions, and new diagnostic tools.

How does Agilent Technologies Inc. contribute to laboratory efficiency?

Agilent enhances laboratory efficiency through comprehensive solutions for sample preparation, data interpretation, and management.

What sustainable practices does Agilent Technologies Inc. emphasize?

Agilent focuses on innovations that improve human health and environmental outcomes, emphasizing sustainability in its practices.

Why do scientists and researchers trust Agilent Technologies Inc.?

Scientists and researchers trust Agilent for its reliable solutions that meet complex laboratory demands and enable significant insights.

What kind of global issues does Agilent Technologies Inc. address?

Agilent addresses global issues related to human health and the environment, anticipating future scientific needs.
Agilent Technologies Inc.

NYSE:A

A Rankings

A Stock Data

43.00B
284.65M
Analytical Laboratory Instrument Manufacturing
Laboratory Analytical Instruments
Link
United States of America
SANTA CLARA